Colfax Reports Second Quarter 2008 Financial Results

RICHMOND, Va., Aug. 5 /PRNewswire-FirstCall/ -- Colfax Corporation
(NYSE: CFX), a global leader in engineered fluid handling products and
systems, today announced financial results for the second quarter ended June
27, 2008. Colfax completed its initial public offering on May 8, 2008. On a
year-over-year basis, highlights for the quarter and the first half of 2008
include:
(Logo: http://www.newscom.com/cgi-bin/prnh/20080508/DC21739LOGO )
Second Quarter of 2008 (all comparisons versus the second quarter of 2007,
unless otherwise noted)
-- Adjusted net income (as defined below) of $13.9 million (32 cents per
share), an increase of 53.0%; Net loss of $31.4 million ($1.01 per share)
-- Net sales of $161.4 million, an increase of 31.9%; Organic sales growth
(as defined below) of 18.3%
-- Adjusted operating income (as defined below) of $23.6 million, an
increase of 42.1%; Operating loss of $40.8 million
-- Adjusted EBITDA (as defined below) of $27.5 million, an increase of
32.5%; EBITDA (as defined below) of $(36.9) million
-- Record second quarter orders of $188.8 million, an increase of 34.3%;
Organic order growth (as defined below) of 18.8%
-- Record backlog of $384.0 million
First Half of 2008 (all comparisons versus the first half of 2007, unless
otherwise noted)
-- Adjusted net income (as defined below) of $24.0 million (55 cents per
share), an increase of 43.9%; Net loss of $24.6 million (99 cents per share)
-- Net sales of $292.1 million, an increase of 23.1%; Organic sales growth
(as defined below) of 10.5%
-- Adjusted operating income (as defined below) of $41.9 million, an
increase of 33.8%; Operating loss of $26.0 million
-- Adjusted EBITDA (as defined below) of $49.5 million, an increase of
27.1%; EBITDA (as defined below) of $(18.3) million
-- Record orders for the six month period of $369.1 million, an increase
of 36.0%; Organic order growth (as defined below) of 21.4%
Adjusted net income, adjusted net income per share, adjusted operating
income, EBITDA, adjusted EBITDA, organic sales growth and organic order growth
are not financial measures calculated in accordance with generally accepted
accounting principles ("GAAP"). See below for a description of the measures'
usefulness and a reconciliation of these measures to their most directly
comparable GAAP financial measures.
"We are pleased with our second quarter results," said John Young,
President and CEO of Colfax Corporation. "We continue to benefit from the
global investment in infrastructure and the robust demand for our fluid
handling products across our key strategic markets. Our strong organic growth
rate of 18% was driven by demand in our commercial marine, power generation
and general industrial end markets. Trends in order rates and backlog remain
favorable with orders up 34% for the quarter and backlog reaching an all-time
high of $384 million at quarter-end. With these positive market trends and
our strengthened balance sheet resulting from our successful IPO, we believe
we are well positioned to execute our strategic initiatives and are on track
to deliver low double digit organic sales growth for the balance of the year."
Non-GAAP Financial Measures
Colfax has provided in this press release financial information that has
not been prepared in accordance with GAAP. These non-GAAP financial measures
are adjusted net income, adjusted net income per share, adjusted operating
income, EBITDA, adjusted EBITDA, organic sales growth and organic order
growth. Adjusted net income, adjusted net income per share, adjusted operating
income and adjusted EBITDA exclude asbestos liability and defense cost
(income) and asbestos coverage litigation expense, certain legacy legal
charges, as well as one time initial public offering-related costs. Adjusted
net income also reflects interest expense as if the offering had occurred at
the beginning of the period and presents income taxes at an effective tax rate
of 34%. Organic sales growth and organic order growth exclude the impact of
acquisitions and foreign exchange rate fluctuations. These non-GAAP financial
measures assist Colfax in comparing its operating performance on a consistent
basis because, among other things, they remove the impact of capital
structure, asset base, non-recurring items such as IPO related costs, legacy
asbestos issues (except in the case of EBITDA) and items outside the control
of its operating management team.
Non-GAAP financial measures should not be considered in isolation from, or
as a substitute for, financial information calculated in accordance with GAAP.
Investors are encouraged to review the reconciliation of these non-GAAP
measures to their most directly comparable GAAP financial measures. A
reconciliation of non-GAAP financial measures presented above to GAAP results
has been provided in the financial tables included in this press release.
Conference Call and Webcast
Colfax will host a conference call to provide details about its results
and business strategy on Tuesday, August 5, 2008 at 8:00 a.m. EDT. The call
will be open to the public through 719-325-4935 or 877-440-5804 and webcast
via Colfax's website at http://www.colfaxcorp.com under the "Investor
Relations" section. Access to a supplemental slide presentation can also be
found at the Colfax website under the same heading.
Both the audio of this call and the slide presentation will be archived on
the website later today and will be available until the next quarterly call.
In addition, a replay of this call will be available until approximately
August 22, 2008. The replay number in the U.S. is 888-203-1112 and
internationally it is 719-457-0820, and the access code is 8865744.
About Colfax Corporation
Colfax Corporation is a global leader in critical fluid-handling
solutions, including the manufacture of positive displacement industrial pumps
and valves used in global oil & gas, power generation, marine, naval and a
variety of other industrial applications. Key product brands include
Allweiler, Fairmount Automation, Houttuin, Imo, LSC, Portland Valve, Tushaco,
Warren and Zenith. Colfax is traded on the NYSE under the ticker "CFX."
Additional information about Colfax's products, businesses and practices is
available at www.colfaxcorp.com
CAUTIONARY NOTE CONCERNING FORWARD LOOKING STATEMENTS:
This press release contains forward-looking statements, including forward-
looking statements within the meaning of the Private Securities Litigation
Reform Act of 1995. Such forward-looking statements include, but are not
limited to, statements concerning Colfax's plans, objectives, expectations and
intentions and other statements that are not historical or current facts.
Forward-looking statements are based on Colfax's current expectations and
involve risks and uncertainties that could cause actual results to differ
materially from those expressed or implied in such forward-looking statements.
Factors that could cause Colfax's results to differ materially from current
expectations include, but are not limited to factors detailed in Colfax's
Registration Statement on Form S-1 under the caption "Risk Factors" and other
reports filed with the U.S. Securities and Exchange Commission. In addition,
these statements are based on a number of assumptions that are subject to
change. This press release speaks only as of this date. Colfax disclaims any
duty to update the information herein.

Colfax Corporation
Condensed Consolidated Statement of Operations
(amounts in thousands, except per share data)
(unaudited)

Three Months Ended Six Months Ended
June 27, June 29, June 27, June 29,
2008 2007 2008 2007

Net sales $161,431 $122,426 $292,082 $237,241
Cost of sales 104,654 79,381 187,127 155,377

Gross profit 56,777 43,045 104,955 81,864
Initial public offering
related costs 57,017 - 57,017 -
Selling, general and
administrative expenses 35,776 25,412 64,283 48,516
Research and development
expenses 1,571 1,049 2,952 2,070
Asbestos liability and
defense (income) costs (715) 558 (437) (1,747)
Asbestos coverage
litigation expenses 3,970 3,678 7,109 5,931

Operating (loss) income (40,842) 12,348 (25,969) 27,094
Interest expense 3,236 4,458 7,733 9,216

(Loss) income before
income taxes (44,078) 7,890 (33,702) 17,878
(Benefit) provision for
income taxes (12,679) 3,049 (9,101) 6,999

Net (loss) income $(31,399) $4,841 $(24,601) $10,879

Net (loss) income available
to common shareholders per
share-basic and diluted $(1.01) $0.22 $(0.99) $0.50

Weighted average common
shares 34,525,984 21,885,929 28,311,879 21,885,929

Colfax Corporation
Tables
(amounts in thousands, except per share data)
(unaudited)

Three Months Ended Six Months Ended
June 27, June 29, June 27, June 29,
2008 2007 2008 2007
EBITDA
Net (loss) income $(31,399) $4,841 $(24,601) $10,879

Interest expense 3,236 4,458 7,733 9,216
(Benefit) provision for
income taxes (12,679) 3,049 (9,101) 6,999
Depreciation and
amortization 3,955 4,185 7,650 7,683

EBITDA $(36,887) $16,533 $(18,319) $34,777
EBITDA margin -22.9% 13.5% -6.3% 14.7%

Adjusted EBITDA
Net (loss) income $(31,399) $4,841 $(24,601) $10,879

Interest expense 3,236 4,458 7,733 9,216
(Benefit) provision for
income taxes (12,679) 3,049 (9,101) 6,999
Depreciation and
amortization 3,955 4,185 7,650 7,683
Initial public offering
related costs 57,017 - 57,017 -
Legacy legal adjustment 4,131 - 4,131 -
Asbestos liability and
defense (income) costs (715) 558 (437) (1,747)
Asbestos coverage
litigation expense 3,970 3,678 7,109 5,931

Adjusted EBITDA $27,516 $20,769 $49,501 $38,961
Adjusted EBITDA margin 17.0% 17.0% 16.9% 16.4%

Adjusted Net Income and
Adjusted Earnings per
Share
Net (loss) income $(31,399) $4,841 $(24,601) $10,879
Initial public offering
related costs 57,017 - 57,017 -
Legacy legal adjustment 4,131 - 4,131 -
Asbestos liability and
defense (income) costs (715) 558 (437) (1,747)
Asbestos coverage
litigation expense 3,970 3,678 7,109 5,931
Interest adjustment to
effect IPO at beginning
of period 725 1,636 2,302 3,250
Tax adjustment to 34%
effective rate (19,836) (1,630) (21,484) (1,607)

Adjusted net income $13,893 $9,083 $24,037 $16,706
Adjusted net income margin 8.6% 7.4% 8.2% 7.0%

Shares outstanding at
closing of IPO 44,006,026 44,006,026 44,006,026 44,006,026
Adjusted net income per
share - basic $0.32 $0.21 $0.55 $0.38

Net (loss) income per
share-basic and diluted
in accordance with GAAP $(1.01) $0.22 $(0.99) $0.50

Adjusted Operating Income
Operating (loss) income $(40,842) $12,348 $(25,969) $27,094
Initial public offering
related costs 57,017 - 57,017 -
Legacy legal adjustment 4,131 - 4,131 -
Asbestos liability and
defense (income) costs (715) 558 (437) (1,747)
Asbestos coverage
litigation expense 3,970 3,678 7,109 5,931

Adjusted operating income $23,561 $16,584 $41,851 $31,278
Adjusted operating income
margin 14.6% 13.5% 14.3% 13.2%

Colfax Corporation
Tables
(amounts in millions)
(unaudited)

Sales Orders
$ % $ %

Three Months Ended June 29, 2007 $122.4 $140.6

Components of Growth:
Organic Growth from Existing Businesses 22.4 18.3% 26.5 18.8%
Acquisitions 1.0 0.8% 4.3 3.1%
Foreign Currency Translation 15.6 12.7% 17.4 12.4%

Total Growth 39.0 31.9% 48.2 34.3%

Three Months Ended June 27, 2008 $161.4 $188.8

Sales Orders
$ % $ %

Six Months Ended June 29, 2007 $237.2 $271.4

Components of Growth:
Organic Growth from Existing Businesses 24.8 10.5% 58.1 21.4%
Acquisitions 3.5 1.5% 6.4 2.4%
Foreign Currency Translation 26.6 11.2% 33.2 12.2%

Total Growth 54.9 23.1% 97.7 36.0%

Six Months Ended June 27, 2008 $292.1 $369.1

SOURCE Colfax Corporation

Mitzi Reynolds, Vice President Investor Relations of Colfax Corporation,
+1-804-327-5689